These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34930081)

  • 1. ST2 and galectin-3 as novel biomarkers for the prediction of future cardiovascular disease risk in preeclampsia.
    Atakul N; Atamer Y; Selek Ş; Kılıç B; Koktasoglu F
    J Obstet Gynaecol; 2022 Jul; 42(5):1023-1029. PubMed ID: 34930081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of maternal serum progesterone-induced blocking factor levels in pregnancies complicated with early- and late-onset preeclampsia.
    Sahin E; Madendag Y; Eraslan Sahin M; Col Madendag I; Kirlangic MM; Muhtaroglu S
    J Obstet Gynaecol; 2022 Aug; 42(6):1991-1995. PubMed ID: 35648816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-1 as a novel risk factor for both gestational hypertension and preeclampsia, specifially its expression at a low level in the second trimester and a high level after onset.
    Hirashima C; Ohkuchi A; Nagayama S; Suzuki H; Takahashi K; Ogoyama M; Takahashi H; Shirasuna K; Matsubara S
    Hypertens Res; 2018 Jan; 41(1):45-52. PubMed ID: 28978981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum endothelial cell-specific molecule-1 level and its correlation with severity of early-onset preeclampsia.
    Ovayolu A; Karaman E; Turgut A; Guler S; Bostancieri N
    J Obstet Gynaecol; 2021 Aug; 41(6):893-898. PubMed ID: 33228435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex Analysis of Circulating Maternal Cardiovascular Biomarkers Comparing Preeclampsia Subtypes.
    Lekva T; Sugulle M; Moe K; Redman C; Dechend R; Staff AC
    Hypertension; 2020 Jun; 75(6):1513-1522. PubMed ID: 32336238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure.
    Wang CH; Yang NI; Liu MH; Hsu KH; Kuo LT
    Cardiol J; 2016; 23(5):563-572. PubMed ID: 27515479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Galectin-3 Levels Are Unlikely to Be a Useful Predictive Marker for Early-onset Preeclampsia Development.
    Nikolov A; Popovski N; Blazhev A
    Prague Med Rep; 2020; 121(3):172-180. PubMed ID: 33030146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of plasma cell-free DNA and ST2 as parameters in gestational hypertension and preeclampsia.
    Liu L; Li H; Wang N; Song X; Zhao K; Zhang C
    Hypertens Res; 2021 Aug; 44(8):996-1001. PubMed ID: 33864012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Endocan Levels in Early and Late-Onset Preeclampsia.
    Kucukbas GN; Sanhal CY; Uygur D
    Fetal Pediatr Pathol; 2021 Jun; 40(3):214-221. PubMed ID: 31769346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating cardiovascular biomarkers during and after preeclampsia: Crosstalk with placental function?
    Jacobsen DP; Røysland R; Strand H; Moe K; Sugulle M; Omland T; Staff AC
    Pregnancy Hypertens; 2022 Dec; 30():103-109. PubMed ID: 36148698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum irisin levels in early and late-onset pre-eclamptic and healthy pregnancies.
    Ozel A; Davutoglu EA; Firat A; Erenel H; Karslı MF; Korkmaz SÖ; Madazli R
    J Obstet Gynaecol; 2018 Jul; 38(5):642-646. PubMed ID: 29430974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease risk is only elevated in hypertensive, formerly preeclamptic women.
    Breetveld NM; Ghossein-Doha C; van Kuijk S; van Dijk AP; van der Vlugt MJ; Heidema WM; Scholten RR; Spaanderman ME
    BJOG; 2015 Jul; 122(8):1092-100. PubMed ID: 25139045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of maternal serum SERPINC1, E-selectin, P-selectin, and RBP4 levels in pregnancies with early- and late-onset preeclampsia.
    Palalıoğlu RM; Erbiyik HI
    J Obstet Gynaecol Res; 2023 Mar; 49(3):870-882. PubMed ID: 36604828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation index and pulse wave velocity in normotensive versus preeclamptic pregnancies: a prospective case-control study using a new oscillometric method.
    Anthoulakis C; Mamopoulos A
    Ann Med; 2022 Dec; 54(1):1-10. PubMed ID: 34935572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of galectin-3, thioredoxin and thioredoxin interacting protein in preeclampsia.
    Farladansky-Gershnabel S; Heusler I; Biron-Shental T; Shechter-Maor G; Amiel A; Kidron D; Weisz A; Einbinder Y; Cohen-Hagai K; Benchetrit S; Zitman-Gal T
    Pregnancy Hypertens; 2021 Dec; 26():95-101. PubMed ID: 34700108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia.
    Huang T; Bedford HM; Rashid S; Rasasakaram E; Priston M; Mak-Tam E; Gibbons C; Meschino WS; Cuckle H; Mei-Dan E
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):190. PubMed ID: 35260099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening models combining maternal characteristics and multiple markers for the early prediction of preeclampsia in pregnancy: a nested case-control study.
    Chen L; Pi Y; Chang K; Luo S; Peng Z; Chen M; Yu L
    J Obstet Gynaecol; 2022 Aug; 42(6):1889-1896. PubMed ID: 35634766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible effects of lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms on cardiovascular risk in patients with preeclampsia.
    Güngör ZB; Tüten A; Ekmekçi H; Ekmekçi ÖB; Kucur M; Öncül M; Donma O; Madazlı R; Sönmez H
    J Matern Fetal Neonatal Med; 2018 Dec; 31(23):3119-3127. PubMed ID: 28784006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.